Lorena Baboçi

1.1k total citations
27 papers, 811 citations indexed

About

Lorena Baboçi is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Lorena Baboçi has authored 27 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Otorhinolaryngology and 7 papers in Surgery. Recurrent topics in Lorena Baboçi's work include Head and Neck Cancer Studies (9 papers), Cervical Cancer and HPV Research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Lorena Baboçi is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Cervical Cancer and HPV Research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Lorena Baboçi collaborates with scholars based in Italy, Germany and United States. Lorena Baboçi's co-authors include Annarosa Del Mistro, Michele Dal Bo, Giuseppe Toffoli, Paolo Boscolo‐Rizzo, Maria Cristina Da Mosto, Giancarlo Tirelli, Elena De Mattia, Valentina Lupato, Michael Pawlita and Dana Holzinger and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and International Journal of Cancer.

In The Last Decade

Lorena Baboçi

27 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorena Baboçi Italy 18 281 260 229 215 184 27 811
Fedor Denkers Netherlands 17 353 1.3× 302 1.2× 144 0.6× 523 2.4× 161 0.9× 28 1.0k
Ana Carolina de Carvalho Brazil 18 180 0.6× 239 0.9× 81 0.4× 651 3.0× 151 0.8× 58 1.1k
Clorinda Annunziata Italy 12 100 0.4× 147 0.6× 186 0.8× 286 1.3× 100 0.5× 16 647
Maarten A. Wildeman Netherlands 17 332 1.2× 230 0.9× 80 0.3× 95 0.4× 215 1.2× 24 716
Lucía González‐Ruiz Spain 19 273 1.0× 280 1.1× 69 0.3× 296 1.4× 217 1.2× 40 1.1k
Saara Kantola Finland 10 357 1.3× 372 1.4× 44 0.2× 220 1.0× 178 1.0× 14 835
Kouichiro Tsutsumi Japan 14 92 0.3× 159 0.6× 212 0.9× 185 0.9× 138 0.8× 37 614
Christiane Ostwald Germany 12 145 0.5× 320 1.2× 125 0.5× 132 0.6× 122 0.7× 20 606
Ángela Ayén Spain 16 211 0.8× 168 0.6× 50 0.2× 302 1.4× 171 0.9× 17 950
K Flynn United States 6 182 0.6× 755 2.9× 122 0.5× 176 0.8× 117 0.6× 7 898

Countries citing papers authored by Lorena Baboçi

Since Specialization
Citations

This map shows the geographic impact of Lorena Baboçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Baboçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Baboçi more than expected).

Fields of papers citing papers by Lorena Baboçi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Baboçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Baboçi. The network helps show where Lorena Baboçi may publish in the future.

Co-authorship network of co-authors of Lorena Baboçi

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Baboçi. A scholar is included among the top collaborators of Lorena Baboçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Baboçi. Lorena Baboçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vinante, Lorenzo, Jayant S. Vaidya, Mario Mileto, et al.. (2024). Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer institute. Frontiers in Oncology. 14. 1424630–1424630. 2 indexed citations
2.
Muraro, Elena, Lorenzo Vinante, Elisabetta Fratta, et al.. (2023). Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors. Cancers. 15(9). 2471–2471. 14 indexed citations
3.
Vinante, Lorenzo, Alberto Revelant, F. Bertini, et al.. (2022). Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy. The Breast. 65. 49–54. 6 indexed citations
4.
Montico, Marcella, Marco Trovò, Emilio Minatel, et al.. (2022). Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 115(3). 608–621. 2 indexed citations
5.
Polesel, Jerry, Anna Menegaldo, Giancarlo Tirelli, et al.. (2021). Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 11. 787864–787864. 13 indexed citations
6.
Montico, Barbara, Francesca Colizzi, Giorgio Giurato, et al.. (2020). Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy. Cell Death and Disease. 11(5). 392–392. 13 indexed citations
7.
Bo, Michele Dal, et al.. (2020). The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices. Frontiers in Neuroscience. 14. 603647–603647. 29 indexed citations
8.
Bo, Michele Dal, Elena De Mattia, Lorena Baboçi, et al.. (2020). New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates. 51. 100702–100702. 72 indexed citations
9.
Polano, Maurizio, Marco Chierici, Michele Dal Bo, et al.. (2019). A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning. Cancers. 11(10). 1562–1562. 31 indexed citations
10.
Spinato, Giacomo, Marco Stellin, Giuseppe Azzarello, et al.. (2017). Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus. Oncology Letters. 14(1). 185–193. 9 indexed citations
11.
Holzinger, Dana, Gunnar Wichmann, Lorena Baboçi, et al.. (2017). Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma. International Journal of Cancer. 140(12). 2748–2757. 89 indexed citations
12.
Schroeder, Lea, Paolo Boscolo‐Rizzo, Elisa Dal Cin, et al.. (2017). Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study. European Journal of Cancer. 74. 73–81. 53 indexed citations
13.
Baboçi, Lorena, Dana Holzinger, Paolo Boscolo‐Rizzo, et al.. (2016). Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy. Papillomavirus Research. 2. 133–140. 30 indexed citations
14.
Kostareli, Efterpi, Thomas Hielscher, Manuela Zucknick, et al.. (2016). Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics. 11(1). 61–73. 31 indexed citations
15.
Boscolo‐Rizzo, Paolo, Maria Cristina Da Mosto, Enrica Rampazzo, et al.. (2016). Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer and Metastasis Reviews. 35(3). 457–474. 45 indexed citations
16.
Boscolo‐Rizzo, Paolo, Enrica Rampazzo, Egle Perissinotto, et al.. (2015). Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. Oral Oncology. 51(5). 500–507. 37 indexed citations
17.
Carozzi, Francesca Maria, Laura De Marco, Anna Gillio‐Tos, et al.. (2014). Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. Journal of Clinical Virology. 60(3). 257–263. 25 indexed citations
18.
Baboçi, Lorena, Paolo Boscolo‐Rizzo, Dana Holzinger, et al.. (2013). Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma. Virology Journal. 10(1). 334–334. 17 indexed citations
19.
Boscolo‐Rizzo, Paolo, Annarosa Del Mistro, Francesco Bussu, et al.. (2013). New insights into human papillomavirus-associated head and neck squamous cell carcinoma.. PubMed. 33(2). 77–87. 87 indexed citations
20.
Mistro, Annarosa Del, Lorena Baboçi, Helena Frayle, et al.. (2012). Oral Human Papillomavirus and Human Herpesvirus-8 Infections Among Human Immunodeficiency Virus Type 1–Infected Men and Women in Italy. Sexually Transmitted Diseases. 39(11). 894–898. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026